O2Micro International (OIIM) Stock Forecast, Price & News

1 Wall Street equities research analysts have issued "buy," "hold," and "sell" ratings for O2Micro International in the last twelve months. There are currently 1 hold rating for the stock. The consensus among Wall Street equities research analysts is that investors should "hold" OIIM shares. A hold rating indicates that analysts believe investors should maintain any existing positions they have in OIIM, but not buy additional shares or sell existing shares.
View OIIM analyst ratings or view top-rated stocks.

1 Wall Street research analysts have issued 12-month price targets for O2Micro International's stock. Their OIIM share price forecasts range from $3.50 to $3.50. On average, they expect the company's share price to reach $3.50 in the next twelve months. This suggests that the stock has a possible downside of 28.6%.
View analysts price targets for OIIM or view top-rated stocks among Wall Street analysts.

O2Micro International Limited (NASDAQ:OIIM) announced its earnings results on Thursday, October, 28th. The electronics maker reported $0.12 earnings per share (EPS) for the quarter, beating analysts' consensus estimates of $0.10 by $0.02. The electronics maker earned $27.27 million during the quarter, compared to the consensus estimate of $26.90 million. O2Micro International had a trailing twelve-month return on equity of 2.99% and a net margin of 3.48%. During the same quarter in the prior year, the firm posted $0.10 earnings per share.

18 employees have rated O2Micro International Chief Executive Officer Sterling Du on Glassdoor.com. Sterling Du has an approval rating of 63% among the company's employees. This puts Sterling Du in the bottom 25% of approval ratings compared to other CEOs of publicly-traded companies.

Based on aggregate information from My MarketBeat watchlists, some companies that other O2Micro International investors own include Co-Diagnostics (CODX), Vaxart (VXRT), FuelCell Energy (FCEL), Inovio Pharmaceuticals (INO), Athersys (ATHX), Actinium Pharmaceuticals (ATNM), AVEO Pharmaceuticals (AVEO), Gilead Sciences (GILD), iBio (IBIO) and Novavax (NVAX).

O2Micro International trades on the NASDAQ under the ticker symbol "OIIM."

One share of OIIM stock can currently be purchased for approximately $4.90.

O2Micro International (NASDAQ:OIIM) has a market capitalization of $142.79 million and generates $101.10 million in revenue each year. The electronics maker earns $12.11 million in net income (profit) each year or $0.10 on an earnings per share basis.

The company employs 315 workers across the globe.

O2Micro International's mailing address is Grand Pavilion Commercial Centre West Bay Road, Grand Cayman E9, KY1-1209. The official website for the company is www.o2micro.com. The electronics maker can be reached via phone at (345) 945-1110, via email at ir@o2micro.com, or via fax at 34-59-451-11.